chevron_leftBack
As of 10 June 2026, Kangmei Pharmaceutical Co., Ltd. has a market cap of $3.53B USD, ranking #4850 globally and #1020 in China.
It ranks #373 in the Healthcare sector, and #143 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$3.53BUSD
23.92B CNY
Enterprise Value
$3.38BUSD
22.9B CNY
Revenue (TTM)
$775.44MUSD
5.25B CNY
EBITDA (TTM)
$57.55MUSD
389.44M CNY
Net Income (TTM)
$1.52MUSD
10.33M CNY
EBITDA Margin
7.4%
Profit Margin
0.2%
PE Ratio
2316.4
PS Ratio
4.6
PB Ratio
3.3
EV/EBITDA
55.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Guoxiong Ou
open_in_new
Employees
4,233
Founded
1997
Website
kangmei.com.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.2% | -0.6% | -2.8% | -11% | -16% | -11% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
600518
康美药业股份有限公司 Class A
ISIN: CNE0000017M1
Shares Out.:
Shares Outstanding:
13.829B1
Shares Float:
13.26B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1.71 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Kangmei Pharmaceutical Co., Ltd.
Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. In addition, it engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical institution resources, smart pharmacies, OTC retail, chain drug stores, direct sales, medical e-commerce, mobile medical care, etc. Kangmei Pharmaceutical Co., Ltd. was founded in 1997 and is based in Shenzhen, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.87B
1K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.66B
1K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.51B
707%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
432%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.52B
368%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
353%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
21K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
15K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
10K%
|
97.4
|
|
SIX: RO
|
$321.17B
9K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$287.57B
8K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.35B
8K%
218.9B CHF
|
20.5
|
chevron_leftBack